1998
DOI: 10.1016/s0167-5273(98)00035-7
|View full text |Cite
|
Sign up to set email alerts
|

δ2 opioid receptor subtype on human vascular endothelium uncouples morphine stimulated nitric oxide release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 26 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…Although we currently have no evidence that formation of ROS occurs in animals pretreated 24 hours with d opioids before HS, it is possible that Delt-D var interacts with mitochondria and/or modifies sarcolemmal K ATP channel activity by modulation of redox-sensitive or metabolic mechanisms that trigger ischemic protection and improve the recompensatory phase of hemorrhage. Recent studies 35,36 have shown that d 2 opioid receptors are present throughout the vascular endothelium, where they have been shown to block morphine-stimulated nitric oxide release and NO-mediated vasodilation, and that d opioid receptor activation is involved in regulation of contractile tone resulting in vasoconstriction. Although the latter studies were not conducted utilizing an HS model, they nevertheless raise the possibility that exogenously administered d opioids given immediately after hemorrhage or 24-48 hours before hemorrhage could initiate vasopressor effects during HS that are similar to those seen with vasopressin infusion.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although we currently have no evidence that formation of ROS occurs in animals pretreated 24 hours with d opioids before HS, it is possible that Delt-D var interacts with mitochondria and/or modifies sarcolemmal K ATP channel activity by modulation of redox-sensitive or metabolic mechanisms that trigger ischemic protection and improve the recompensatory phase of hemorrhage. Recent studies 35,36 have shown that d 2 opioid receptors are present throughout the vascular endothelium, where they have been shown to block morphine-stimulated nitric oxide release and NO-mediated vasodilation, and that d opioid receptor activation is involved in regulation of contractile tone resulting in vasoconstriction. Although the latter studies were not conducted utilizing an HS model, they nevertheless raise the possibility that exogenously administered d opioids given immediately after hemorrhage or 24-48 hours before hemorrhage could initiate vasopressor effects during HS that are similar to those seen with vasopressin infusion.…”
Section: Discussionmentioning
confidence: 99%
“…In the vasopressin studies, vasopressin, but not fluid resuscitation, increased MAP and significantly improved survival rates in a pig liver trauma model with otherwise lethal HS. 35 This was believed to occur because of a profound vasopressin-mediated peripheral vasoconstriction via V1 receptors in the vasculature, which shifts blood primarily from the skeletal muscle, skin, and splanchnic bed to heart and brain. 37 It has also been demonstrated in both cardiopulmonary resuscitation and HS studies that vasopressin temporarily impairs mesenteric artery and, subsequently, portal vein blood flow, while arterial reperfusion of the liver and kidneys is restored.…”
Section: Discussionmentioning
confidence: 99%
“…These reports also demonstrate, on a pharmacological and biochemical basis, that the corresponding receptors are present as well, along with the intracellular second messenger communication processes [23][24][25][26]. Opioid peptides and opiate alkaloids (e.g., enkephalins, morphine) are also present with their respective receptors and biosynthetic pathways [27][28][29][30][31]. From a neuroimmune perspective, the same chemical messengers and their receptors have been found on invertebrate immunocytes, including nitric oxide coupling, allowing neurons to communicate with the immune cells, including microglia [32][33][34][35][36][37][38][39][40][41][42] (Figures 1 and 2).…”
Section: Common Set Of Shared Signal Moleculesmentioning
confidence: 92%
“…However, in 1995, the μ 3 subtype of this receptor was detected in the coronary microvascular's endothelial cells . This group of researchers also established that endothelial cells express a δ 2 OR subtype . Vascular smooth muscle cells also appeared to express δ OR .…”
Section: Localization Of Opioid Receptors Involved In Regulation Of Hmentioning
confidence: 96%